Anna Vilborg Hartwig is an R&D Director at Natera with over a decade of leadership in NGS technology and molecular oncology. Her career includes key roles at Exai Bio and Guardant Health, focusing on assay development and validation in regulated environments. She earned her Doctor of Philosophy from the Karolinska Institute.
She has a declared interest in achieving a healthy work-life balance and is passionate about building engaged, collaborative teams that solve important technical and biological problems.
Unique fact: Anna has successfully guided R&D teams in developing liquid biopsy NGS assays and assisted in communications with the FDA for their clinical launch.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.